Axs Investments LLC Dexcom Inc Transaction History

Axs Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $9,662 - $15,892	-128 Reduced 10.26%	1,120 $138,000
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $11,445 - $18,344	-133 Reduced 9.63%	1,248 $116,000
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $2,924 - $3,405	26 Added 1.92%	1,381 $177,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $16,952 - $20,035	-163 Reduced 10.74%	1,355 $157,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $128,999 - $186,213	1,518 New	1,518 $171,000
Q2 2022 Aug 11, 2022	SELL	$67.99 - $132.89 $37,122 - $72,557	-546 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $19,286 - $26,690	-205 Reduced 27.3%	546 $279,000
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $97,532 - $122,277	751 New	751 $403,000
Q3 2021 Nov 05, 2021	SELL	$106.71 - $143.18 $137,229 - $184,129	-1,286 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$80.99 - $107.93 $17,979 - $23,960	222 Added 20.86%	1,286 $549,000
Q1 2021 May 10, 2021	BUY	$84.79 - $104.74 $90,216 - $111,443	1,064 New	1,064 $382,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Axs Investments LLC with notifications on news.